Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walt Disney
DIS
|
+$655M |
| 2 |
Coty
COTY
|
+$380M |
| 3 |
ConocoPhillips
COP
|
+$250M |
| 4 |
Zimmer Biomet
ZBH
|
+$213M |
| 5 |
Valero Energy
VLO
|
+$170M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$523M |
| 2 |
Merck
MRK
|
+$375M |
| 3 |
SHPG
Shire pic
SHPG
|
+$362M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$310M |
| 5 |
CELG
Celgene Corp
CELG
|
+$286M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 13.57% |
| 2 | Technology | 12.05% |
| 3 | Financials | 10.74% |
| 4 | Consumer Discretionary | 9.44% |
| 5 | Energy | 8.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
eBay
EBAY
$47.3B
| $228M | 0.34% |
6,134,426
-1,429,207
| -19% | -$49.6M |
|
27
PUT
iShares Russell 2000 ETF
IWM
$81.5B
| $223M | 0.33% |
1,455,300
+640,800
| +79% | +$96.3M |
|
28
Intuitive Surgical
ISRG
$133B
| $220M | 0.33% |
1,154,802
+330,741
| +40% | +$58.8M |
|
29
Sysco
SYY
$40.2B
| $208M | 0.31% |
3,122,017
+2,267,679
| +265% | +$148M |
|
|
PE
30
DELISTED
PARSLEY ENERGY INC
PE
| $196M | 0.29% |
10,174,372
+8,670,180
| +576% | +$159M |
|
31
Marathon Petroleum
MPC
$101B
| $192M | 0.29% |
3,200,604
+2,023,519
| +172% | +$127M |
|
32
Pfizer
PFE
$159B
| $189M | 0.28% |
4,700,014
+3,502,649
| +293% | +$140M |
|
|
WP
33
DELISTED
Worldpay, Inc.
WP
| $189M | 0.28% |
1,662,671
+627,706
| +61% | +$56.9M |
|
34
McDonald's
MCD
$193B
| $188M | 0.28% |
990,210
+731,260
| +282% | +$133M |
|
35
CALL
Invesco QQQ Trust
QQQ
$483B
| $188M | 0.28% |
1,044,600
+204,500
| +24% | +$34.7M |
|
|
36
CALL
iShares Russell 2000 ETF
IWM
$81.5B
| $187M | 0.28% |
1,224,400
+29,300
| +2% | +$4.4M |
|
37
Capital One
COF
$134B
| $181M | 0.27% |
2,216,592
+143,765
| +7% | +$11.7M |
|
38
Boston Scientific
BSX
$71.5B
| $179M | 0.27% |
4,669,394
-21,458
| -0.5% | -$820K |
|
39
Elevance Health
ELV
$87B
| $178M | 0.27% |
618,760
+351,728
| +132% | +$102M |
|
|
40
Valero Energy
VLO
$99.4B
| $177M | 0.26% |
2,084,406
+2,062,173
| +9,275% | +$170M |
|
41
Citigroup
C
$221B
| $175M | 0.26% |
2,806,072
-3,166,744
| -53% | -$197M |
|
42
Masco
MAS
$14.4B
| $173M | 0.26% |
4,411,928
+1,882,361
| +74% | +$67.1M |
|
43
Meta Platforms (Facebook)
META
$1.42T
| $172M | 0.26% |
1,028,961
-515,670
| -33% | -$82M |
|
44
Chevron
CVX
$397B
| $171M | 0.26% |
1,385,078
+1,026,845
| +287% | +$121M |
|
45
T. Rowe Price
TROW
$23.9B
| $168M | 0.25% |
1,674,494
+1,298,999
| +346% | +$125M |
|
46
Regions Financial
RF
$26.1B
| $163M | 0.24% |
11,551,009
+1,633,386
| +16% | +$25M |
|
47
Ascendis Pharma A/S
ASND
$16.4B
| $162M | 0.24% |
1,378,309
+1,194,634
| +650% | +$105M |
|
|
VAR
48
DELISTED
Varian Medical Systems, Inc.
VAR
| $161M | 0.24% |
1,139,364
-26,191
| -2% | -$3.44M |
|
49
Ovintiv
OVV
$18B
| $160M | 0.24% |
4,406,645
+3,249,835
| +281% | +$111M |
|
50
Starbucks
SBUX
$123B
| $159M | 0.24% |
2,136,066
-3,920,346
| -65% | -$269M |
|
Similar funds
Israel Englander's Q1 2019 Portfolio in Review
As of Q1 2019, Israel Englander held 4,608 positions worth $66.8B, up 4.2% from $64.1B the previous quarter. Its ten largest holdings account for 7.1% of the portfolio.
Israel Englander withdrew a net $6.14B in Q1 2019, closing 675 positions and reducing 1,467 holdings. Its most notable exit was Merck, an estimated $375M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 14% of assets, down from 14% a quarter earlier, followed by Technology and Financials.
Against the trend, Israel Englander opened a new position in Zimmer Biomet worth $232M.
- Israel Englander's largest Q1 2019 buy was Zimmer Biomet: 1,870,503 shares worth $232M.
- Israel Englander added most to Walt Disney in Q1 2019, an estimated $655M increase.
- Israel Englander's biggest Q1 2019 reduction was Apple, cutting an estimated $523M.
- Israel Englander fully exited Merck in Q1 2019, selling an estimated $375M.
- Israel Englander's ten largest holdings make up 7.1% of its $66.8B portfolio in Q1 2019.
- Israel Englander opened 914 new positions and closed 675 in Q1 2019.
- Israel Englander's portfolio value rose 4.2% quarter-over-quarter to $66.8B.
Based on Millennium Management's 13F filing for Q1 2019, filed 14 May 2019.